Table 1.

Summary of the results of TGF-β1 and TGF-β2 ELISAs

Vector Aprotinin (50 μg/mL)Active TGF-β (pg/mL) Total TGF-β (pg/mL)
TGF-β1 TGF-β2 TGF-β1 TGF-β2
pClneo  −  20.2 ± 3.3  18.1 ± 3.0 850 ± 64  1035 ± 65  
pClneo  +  15.2 ± 2.2 14.7 ± 2.0  963 ± 47  851 ± 126 
Zf9-pClneo −  65.3 ± 7.2* 48.6 ± 6.5* 1,029 ± 47* 1,118 ± 51 
Zf9-pClneo +  37.4 ± 1.1 29.8 ± 1.0 1,041 ± 79  1,035 ± 53 
Vector Aprotinin (50 μg/mL)Active TGF-β (pg/mL) Total TGF-β (pg/mL)
TGF-β1 TGF-β2 TGF-β1 TGF-β2
pClneo  −  20.2 ± 3.3  18.1 ± 3.0 850 ± 64  1035 ± 65  
pClneo  +  15.2 ± 2.2 14.7 ± 2.0  963 ± 47  851 ± 126 
Zf9-pClneo −  65.3 ± 7.2* 48.6 ± 6.5* 1,029 ± 47* 1,118 ± 51 
Zf9-pClneo +  37.4 ± 1.1 29.8 ± 1.0 1,041 ± 79  1,035 ± 53 

The concentration of active and total TGF-β1 as well as TGF-β2 in each conditioned medium prepared in Figure 6 was determined by subtype-specific ELISAs as described in “Materials and Methods.” Each value represents the average ± SD from triplicate determinations. Each experiment was repeated 3 times with similar results in all, and representative results are shown.

*

P values obtained by a comparison between pClneo andZf9-pClneo are less than 0.05 except for total TGF-β2 concentration.

P values obtained by a comparison betweenZf9-pClneo and Zf9-pClneo + aprotinin are less than 0.05 for both active TGF-β1 and TGF-β2 concentrations.